About SGD Pharma
SGD Pharma is a Healthcare company based in Puteaux (France) founded in 1998, and was acquired by PAI Partners in June 2021. Pharmaceutical packaging products are manufactured for global markets. The company has 572 employees. Its chief executive, as recorded, is Olivier Rousseau. Its website sgd-pharma.com draws about 12 thousand monthly visits. Its Indian entity Sgd Pharma India Private Limited reported revenue of ₹361 Cr. Its focus areas include Medical Supplies and Consumables and Packaging.
Company details
SGD Pharma was established in 1998 and is headquartered in Puteaux, France. Operations focus on the production of pharmaceutical packaging solutions, including vials, syringes, and containers, within the healthcare sector. Services encompass design, manufacturing, and distribution to support drug delivery needs. The company operates internationally, with facilities across Europe, Asia, and the Americas to meet regulatory standards and supply chain requirements. Leadership is provided by CEO Olivier Rousseau.
- Headquarters Puteaux, France
- Employees 572
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website sgd-pharma.com
- Social LinkedIn Facebook
- Acquired by PAI Partners (Jun 2021)
- Legal Name Sgd Pharma India Private Limited
- Date of Incorporation 13 Nov, 2009
- Jurisdiction Mahbubnagar, Telangana, India
- Indian entity revenue₹361 Cr
FY 2022 · +13% YoY
- Indian entity net profit₹36.47 Cr
FY 2022 · 10% margin
- Indian entity EBITDA₹88.32 Cr
FY 2022 · 24% margin
- InvestorsOaktree Capital Management
& 4 more
- Employee Count572
- Acquired by
Associated legal entities of SGD Pharma
SGD Pharma operates through Sgd Pharma India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sgd Pharma India Private Limited CIN U26100TG2009PTC065810 | Active | 13 Nov 2009 | Mahbubnagar, Telangana | ₹361 Cr | 572 | 5 | View details |
Investors in SGD Pharma
SGD Pharma has secured backing from 5 investors, including venture fund investors. Prominent investors backing the company include Oaktree Capital Management, Sagard and PAI Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Real estate fund, infrastructure fund, and private equity firm focused on multiple sectors | 1995 | oaktreecapital.com | Los Angeles, United States | |
Private equity investments in market-leading companies across global sectors. | paipartners.com | |||
| jicinv.com | ||||
Private equity investments are directed across multiple sectors. | 2002 | sagard.com | Paris, France | |
A European mid-market private equity firm is operated. | cognetas.com | Paris, France |
Investor details for SGD Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Sgd Pharma India Private Limited (SGD Pharma)
Sgd Pharma India Private Limited is the primary company behind SGD Pharma. The board of Sgd Pharma India Private Limited currently have 3 directors; the longest-serving is Olivier Rousseau Jean Francois, appointed in 2022. 34 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Olivier Rousseau Jean Francois DIN 09757736 | Director | 06 Oct 2022 | 4 yrs | Sgd Pharma India Private Limited |
| Philippe Henry Max Pourquery DIN 10679984 | Director | 24 Jun 2024 | 2 yrs 4 mo | Sgd Pharma India Private Limited |
| Deepak Sood DIN 06915150 | Managing Director | 27 Aug 2024 | 2 yrs 2 mo | Sgd Pharma India Private Limited |
People of SGD Pharma
79 people are tracked at SGD Pharma (30 in leadership, 49 in team); the tracked headcount is 572.
| Name | Role | Group |
|---|---|---|
| CEO | Leadership | |
Amit Varma | Assistant General Manager | Leadership |
Nishant Desai | Vice President | Leadership |
Sergio Sato | Head Of South America | Leadership |
Sathaiya Ganapathy | Senior Vice President Quality | Leadership |
Fabio Invernizzi - Change Management | Executive Committee Member, General Manager BU West | Leadership |
Mukul Kumar Sonthalia | Chief Financial Officer | Leadership |
Pavan Kumar E V | Associate Vice President | Leadership |
Alexandre le Chippey | Sales Director - Europe, Middle East & Africa | Leadership |
Jin Coco | Sales Director For Healthcare | Leadership |
Poojitha Reddy | Deputy General Manager Of Sales | Leadership |
Stéphanie D'Agostino | Head Of Accounting Reporting Tax | Leadership |
Thomas Roche | Head Of Treasury, Financing & Credit Management | Leadership |
Katrin Hopfenbeck | HR Director / Bereichsleiterin Personal | Leadership |
John Farmer | North American Director Of Human Resources | Leadership |
Luc Deffontaines | Technical & Engineering Director | Leadership |
Scott J. Beals | Sales Director North America | Leadership |
Sheherazade Chamlou | Vice President Of Sales | Leadership |
Frédéric de Keréver | Vice President Sales EMEA | Leadership |
Mehdi Chafai | Group Director, Commercial Performance & Sales Planning | Leadership |
59 more people are available in the full profile.
Complete people profiles for SGD Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of SGD Pharma
Figures of Sgd Pharma India Private Limited, the primary company behind SGD Pharma, for FY 2022. Revenue was ₹361 Cr (+13% year on year). Net profit was ₹36.47 Cr (10% margin). EBITDA was ₹88.32 Cr (24% margin). Revenue has grown at a compounded annual rate of +30% over three years and +23% over five years.
- ₹361 CrRevenue · FY 2022 · +13% YoY
- ₹36.47 CrNet profit · 10% margin
- ₹88.32 CrEBITDA · 24% margin
- ₹207 CrPaid-up capital
- 572Employees (provident fund records)
- +30%Revenue CAGR, 3 years
- +23%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sgd Pharma India Private Limited are on its company page.
Detailed financial statements for SGD Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of SGD Pharma
5 dated milestones of SGD Pharma across 23 years, from founding to its latest funding, stage changes and deals.
- Founded SGD Pharma is founded.
- Exit Acquired by Sagard.
- Exit Acquired by Oaktree Capital Management.
- Exit Acquired by JIC Investment.
- Exit Acquired by PAI Partners.
Web traffic of SGD Pharma
The website of SGD Pharma (sgd-pharma.com) receives about 12.2K visits a month.
- Monthly visits12.2K
▼ 16.4% vs previous month
Websites whose visitors overlap most with SGD Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| verescence.com | 100% | 6.5K | #2,438,886 | View details | |
| gerresheimer.com | 90% | 35.5K | #769,059 | View details | |
mdtech.fr | mdtech.fr | 75% | #4,550,979 | – | |
industrie.com | industrie.com | 55% | – | ||
| apg-pharma.com | 32% | #6,531,129 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for SGD Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SGD Pharma
SGD Pharma was founded in 1998.
SGD Pharma is headquartered in Puteaux, France. It is registered at Puteaux, Hauts-de-seine, France.
Olivier Rousseau is the CEO of SGD Pharma, as recorded in our data.
SGD Pharma has 572 employees.
The primary company behind SGD Pharma, Sgd Pharma India Private Limited, reported revenue of ₹361 Cr for FY 2022, up 13% year on year.
SGD Pharma was established in 1998 and is headquartered in Puteaux, France. Operations focus on the production of pharmaceutical packaging solutions, including vials, syringes, and containers, within the healthcare sector. Services encompass design, manufacturing, and distribution to support drug delivery needs. The company operates internationally, with facilities across Europe, Asia, and the Americas to meet regulatory standards and supply chain requirements. Leadership is provided by CEO Olivier Rousseau.
SGD Pharma has 5 investors. Key investors include Oaktree Capital Management, Sagard, PAI Partners, Motion Equity Partners, and JIC Investment.
SGD Pharma operates through Sgd Pharma India Private Limited.
Yes. SGD Pharma was acquired by PAI Partners in June 2021.
The legal entities of SGD Pharma currently have 5 directors, including Mukul Kumar, Deepak Sood, Olivier Rousseau Jean Francois and others.